Reversible nyctalopia and retinopathy in a patient with metastatic cancer treated with anti-heat shock protein 90 therapy. [electronic resource]
Producer: 20140919Description: 899-901 p. digitalISSN:- 2168-6173
- Adenocarcinoma -- drug therapy
- Aged
- Autoantibodies -- blood
- Autoantigens -- immunology
- Electroretinography
- Erlotinib Hydrochloride
- HSP90 Heat-Shock Proteins -- antagonists & inhibitors
- Humans
- Infusions, Intravenous
- Isoxazoles -- administration & dosage
- Lung Neoplasms -- drug therapy
- Male
- Night Blindness -- chemically induced
- Paraneoplastic Syndromes, Ocular -- chemically induced
- Phosphopyruvate Hydratase -- immunology
- Quinazolines -- administration & dosage
- Resorcinols -- administration & dosage
- Retina -- drug effects
- Tomography, Optical Coherence
- Visual Acuity -- physiology
No physical items for this record
Publication Type: Case Reports; Letter; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.